Ketosteril® (Tablets) Instructions for Use
ATC Code
V06DD (Amino acids, including combinations with polypeptides)
Clinical-Pharmacological Group
Drug of keto analogues of amino acids, used for renal failure
Pharmacotherapeutic Group
Therapeutic nutrition; other therapeutic nutrition products; amino acids, including combinations with polypeptides
Pharmacological Action
A combined medicinal product. It provides a complete supply of essential amino acids with minimal nitrogen intake. The keto analogues of amino acids are enzymatically transaminated in the body into the corresponding L-amino acids, simultaneously breaking down urea.
It promotes the utilization of nitrogenous metabolic products and protein anabolism while reducing the serum urea concentration. It improves nitrogen metabolism. It reduces the concentration of potassium ions, magnesium, and phosphate in the blood.
Systematic use of this medicinal product has been noted to improve the condition of patients with chronic renal failure. In some cases, it is possible to delay the initiation of dialysis.
Indications
Protein-energy malnutrition, prevention and treatment of disorders caused by altered protein metabolism in chronic renal failure and during dietary protein restriction (in adults and children aged 3 years and older).
Primarily for patients with a GFR <25 ml/min, which does not exclude use at GFR ≥25 ml/min.
ICD codes
| ICD-10 code | Indication |
| E46 | Unspecified protein-energy malnutrition |
| N18 | Chronic kidney disease |
| ICD-11 code | Indication |
| 5B50 | Deficiency of weight in infants, children and adolescents |
| 5B51 | Exhaustion in infants, children and adolescents |
| 5B52 | Acute protein-energy malnutrition in infants, children and adolescents |
| 5B53 | Growth delay in infants, children and adolescents |
| 5B54 | Underweight in adults |
| 5B71 | Protein deficiency |
| GB61.Z | Chronic kidney disease, unspecified stage |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Tablets
Orally, usually 3 times/day with meals.
Adults and children aged 3 years and older are prescribed 1 tablet/5 kg of body weight/day or 100 mg/kg of body weight/day. For adults with a body weight of 70 kg, the dose is usually 4-8 tablets 3 times/day.
It is used throughout the period when the GFR is less than 25 ml/min.
In the pre-dialysis period, it is recommended that the dietary protein content does not exceed 40 g/day, depending on the degree of chronic renal failure.
In patients on dialysis, protein intake should comply with accepted recommendations.
The recommended dietary protein content for children 3-10 years old is 1.4-0.8 g/kg/day, for children over 10 years old – 1-0.6 g/kg/day.
Adverse Reactions
Metabolism in individual cases – hypercalcemia.
Contraindications
Hypercalcemia; disorders of amino acid metabolism; hypersensitivity to the components included in the dosage form of the drug used.
In hereditary phenylketonuria, it should be taken into account that the dosage form of the drug used may contain phenylalanine.
Use in Pregnancy and Lactation
Clinical experience with use during pregnancy and breastfeeding is insufficient.
Use in Renal Impairment
Primarily for patients with a glomerular filtration rate of less than 25 ml/min (however, use at a glomerular filtration rate of more than 25 ml/min is not excluded).
Pediatric Use
Can be used in children aged 3 years and older according to indications and in doses taking into account the age of the patients.
Special Precautions
In case of hypercalcemia, it is recommended to reduce the dose of vitamin D taken. If hypercalcemia persists, the dose of this medicinal product, as well as other sources of calcium, should be reduced.
It is necessary to regularly monitor the calcium content and control the decrease in phosphate levels in the blood serum.
To improve its absorption and conversion into the corresponding amino acids, this medicinal product should be taken with meals.
Sufficient caloric intake from food must be ensured.
Drug Interactions
With the simultaneous administration of medicinal products containing calcium, an increase in serum calcium levels is possible.
As uremic symptoms decrease under the influence of this medicinal product, the dose of simultaneously used aluminum hydroxide should be reduced accordingly.
A decrease in serum phosphate levels should be monitored.
In order not to impair intestinal absorption, medicinal products that form poorly soluble compounds with calcium (for example, tetracyclines, quinolones, preparations containing iron, fluoride, and estramustine) should not be taken simultaneously. The interval between doses should be at least 2 hours.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Film-coated tablets: 100 pcs.
Marketing Authorization Holder
Fresenius Kabi Deutschland, GmbH (Germany)
Manufactured By
BEIJING FRESENIUS KABI PHARMACEUTICAL, Co.Ltd. (China)
Dosage Form
| Ketosteril® | Film-coated tablets: 100 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets yellow, oblong, biconvex.
| 1 tab. | |
| DL-methyl-oxo-2-calcium valerinate (α-keto analogue of isoleucine) | 67 mg |
| Methyl-4-oxo-2-calcium valerate (α-keto analogue of leucine) | 101 mg |
| Oxo-2-phenyl-3-calcium propionate (α-keto analogue of phenylalanine) | 68 mg |
| Methyl-oxo-2-calcium butyrate (α-keto analogue of valine) | 86 mg |
| DL-hydroxy-2-calcium methylbutyrate (α-hydroxy analogue of methionine) | 59 mg |
| L-lysine monoacetate | 105 mg |
| L-threonine | 53 mg |
| L-tryptophan | 23 mg |
| L-Histidine | 38 mg |
| L-tyrosine | 30 mg |
| Total nitrogen content 36 mg calcium content 1.25 mmol (50 mg) |
|
Excipients: corn starch – 44 mg, povidone – 6 mg, talc – 19.57 mg, colloidal silicon dioxide – 4.4 mg, magnesium stearate – 15 mg, macrogol 6000 – 12.8 mg, soluble povidone – 43.2 mg.
Shell composition: talc – 9.1 mg, macrogol 6000 – 1.48 mg, quinoline yellow (E104) – 0.72 mg, copolymer of methyl methacrylate, dimethylaminoethyl methacrylate and butyl methacrylate (eudragit E12.5) – 5.9 mg, triacetin – 0.43 mg, titanium dioxide – 7.4 mg.
20 pcs. – blisters (5) – sealed Al/PVC bags (1) – cardboard packs.
Film-coated tablets: 100 pcs.
Marketing Authorization Holder
Fresenius Kabi Deutschland, GmbH (Germany)
Manufactured By
Labesfal-Laboratorios Almiro, S.A. (Portugal)
Dosage Form
| Ketosteril® | Film-coated tablets: 100 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets yellow, oblong, biconvex.
| 1 tab. | |
| DL-methyl-oxo-2-calcium valerinate (α-keto analogue of isoleucine) | 67 mg |
| Methyl-4-oxo-2-calcium valerate (α-keto analogue of leucine) | 101 mg |
| Oxo-2-phenyl-3-calcium propionate (α-keto analogue of phenylalanine) | 68 mg |
| Methyl-oxo-2-calcium butyrate (α-keto analogue of valine) | 86 mg |
| DL-hydroxy-2-calcium methylbutyrate (α-hydroxy analogue of methionine) | 59 mg |
| L-lysine monoacetate | 105 mg |
| L-threonine | 53 mg |
| L-tryptophan | 23 mg |
| L-Histidine | 38 mg |
| L-tyrosine | 30 mg |
| Total nitrogen content 36 mg calcium content 1.25 mmol (50 mg) |
|
Excipients: corn starch – 44 mg, povidone – 6 mg, talc – 19.57 mg, colloidal silicon dioxide – 4.4 mg, magnesium stearate – 15 mg, macrogol 6000 – 12.8 mg, soluble povidone – 43.2 mg.
Shell composition: talc – 9.1 mg, macrogol 6000 – 1.48 mg, quinoline yellow (E104) – 0.72 mg, copolymer of methyl methacrylate, dimethylaminoethyl methacrylate and butyl methacrylate (eudragit E12.5) – 5.9 mg, triacetin – 0.43 mg, titanium dioxide – 7.4 mg.
20 pcs. – blisters (5) – sealed Al/PVC bags (1) – cardboard packs.
Film-coated tablets: 100 pcs.
Marketing Authorization Holder
Fresenius Kabi Deutschland, GmbH (Germany)
Manufactured By
Fresenius Kabi Deutschland, GmbH (Germany)
Dosage Form
| Ketosteril® | Film-coated tablets: 100 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets yellow, oblong, biconvex.
| 1 tab. | |
| DL-methyl-oxo-2-calcium valerinate (α-keto analogue of isoleucine) | 67 mg |
| Methyl-4-oxo-2-calcium valerate (α-keto analogue of leucine) | 101 mg |
| Oxo-2-phenyl-3-calcium propionate (α-keto analogue of phenylalanine) | 68 mg |
| Methyl-oxo-2-calcium butyrate (α-keto analogue of valine) | 86 mg |
| DL-hydroxy-2-calcium methylbutyrate (α-hydroxy analogue of methionine) | 59 mg |
| L-lysine monoacetate | 105 mg |
| L-threonine | 53 mg |
| L-tryptophan | 23 mg |
| L-Histidine | 38 mg |
| L-tyrosine | 30 mg |
| Total nitrogen content 36 mg calcium content 1.25 mmol (50 mg) |
|
Excipients: corn starch – 44 mg, povidone – 6 mg, talc – 19.57 mg, colloidal silicon dioxide – 4.4 mg, magnesium stearate – 15 mg, macrogol 6000 – 12.8 mg, soluble povidone – 43.2 mg.
Shell composition: talc – 9.1 mg, macrogol 6000 – 1.48 mg, quinoline yellow (E104) – 0.72 mg, copolymer of methyl methacrylate, dimethylaminoethyl methacrylate and butyl methacrylate (eudragit E12.5) – 5.9 mg, triacetin – 0.43 mg, titanium dioxide – 7.4 mg.
20 pcs. – blisters (5) – sealed Al/PVC bags (1) – cardboard packs.
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Phenibut-Vertex pills 250mg, 20pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Fenotropil pills 100mg, 60pcs
Mildronate capsules 500mg, 90pcs
Cortexin, 10mg, 5ml, 10pcs
Kagocel pills 12mg, 30pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Actovegin pills 200mg, 50pcs
Belosalic, lotion solution for external use spray 100ml 